EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains

Lorena Bernardo, Ana Victoria Ibarra-Meneses, Noelie Douanne, Audrey Corbeil, Jose Carlos Solana, Francis Beaudry, Eugenia Carrillo, Javier Moreno, Christopher Fernandez-Prada iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Lorena Bernardo und 8 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Leishmaniasis, Spanish National Center for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Sp…. Hauptthemen laut MEDLINE: Leishmania infantum, Antiprotozoal Agents, Leishmaniasis, Visceral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC), Canada foundation for Innovation, Canada Research Chair in metrology of bioactive molecule and target discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Visceral leishmaniasis (VL) resolution depends on a wide range of factors, including the instauration of an effective treatment coupled to a functional host immune system. Patients with a depressed immune system, like the ones receiving methotrexate (MTX), are at higher risk of developing VL and refusing antileishmanial drugs. Moreover, the alarmingly growing levels of antimicrobial resistance, especially in endemic areas, contribute to the increasing the burden of this complex zoonotic disease. Principal findings To understand the potential links between immunosuppressants and antileishmanial drugs, we have studied the interaction of antimony (Sb) and MTX in a Leishmania infantum reference strain ( Li WT) and in two L . infantum clinical strains ( Li FS-A and Li FS-B) naturally circulating in non-treated VL dogs in Spain. The Li FS-A strain was isolated before Sb treatment in a case that responded positively to the treatment, while the Li FS-B strain was recovered from a dog before Sb treatment, with the dog later relapsing after the treatment. Our results show that, exposure to Sb or MTX leads to an increase in the production of reactive oxygen species (ROS) in Li WT which correlates with a sensitive phenotype against both drugs in promastigotes and intracellular amastigotes. Li FS-A was sensitive against Sb but resistant against MTX, displaying high levels of protection against ROS when exposed to MTX. Li FS-B was resistant to both drugs. Evaluation of the melting proteomes of the two Li FS, in the presence and absence of Sb and MTX, showed a differential enrichment of direct and indirect targets for both drugs, including common and unique pathways.

Conclusion

Our results show the potential selection of Sb-MTX cross-resistant parasites in the field, pointing to the possibility to undermine antileishmanial treatment of those patients being treated with immunosuppressant drugs in Leishmania endemic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania infantumAntiprotozoal AgentsLeishmaniasis, VisceralHumansAnimalsDogsMethotrexateAntimonyReactive Oxygen SpeciesDrug Resistance

Substanzen

MethotrexateAntimonyReactive Oxygen SpeciesAntiprotozoal Agents

Autor:innen und Institutionen

  • WHO Collaborating Centre for Leishmaniasis, Spanish National Center for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
  • Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
  • The Research Group on Infectious Diseases in Production Animals (GREMIP), Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
  • Département de Biomédecine, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
  • Centre de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, Montréal, Quebec, Canada.

ORCID-Profile: Christopher Fernandez-Prada

Förderung

  • Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Canada foundation for Innovation
  • Canada Research Chair in metrology of bioactive molecule and target discovery
  • Instituto de Salud Carlos III
  • Canada Research Chairs
  • ISCIII-AESI
  • CIBERINFEC

Zitieren

APA

Bernardo, L., Ibarra-Meneses, A. V., Douanne, N., Corbeil, A., Solana, J. C., Beaudry, F., Carrillo, E., Moreno, J., & Fernandez-Prada, C. (2024). Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012015

Vancouver

Bernardo L, Ibarra-Meneses AV, Douanne N, Corbeil A, Solana JC, Beaudry F, et al. Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012015

BibTeX
@article{Bernardo2024,
  author = {Bernardo, Lorena and Ibarra-Meneses, Ana Victoria and Douanne, Noelie and Corbeil, Audrey and Solana, Jose Carlos and Beaudry, Francis and Carrillo, Eugenia and Moreno, Javier and Fernandez-Prada, Christopher},
  title = {Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012015}
}
Kostenlos starten →